Dave Briggs :protein: on Nostr: It remains to be seen whether the Nature Springer acquisition of Protocols.io is a ...
Published at
2024-05-18 08:00:06Event JSON
{
"id": "9de990a7b194e6520a2671a18c14fb2263041cec598a3d1b8bd9d91bb127fe74",
"pubkey": "714624df9f9b4226b766ca046285c2f329a9fa52a535278ca762df65536193d1",
"created_at": 1716019206,
"kind": 1,
"tags": [
[
"t",
"Science"
],
[
"t",
"research"
],
[
"proxy",
"https://xtaldave.net/users/xtaldave/statuses/112461034721934677",
"activitypub"
]
],
"content": "It remains to be seen whether the Nature Springer acquisition of Protocols.io is a good thing or not... #Science #Research\n\nhttps://www.nature.com/articles/s41596-024-01012-z",
"sig": "cc84bf7ec8dd969f5d54698f62295f7699f0d4fe985b8a224be7650cabfae47bc8abff1fbc37454c720fbf2fed0356e2c06cb213c77ec3356300d2e8da703f18"
}
